Biotech, Food, Drug

The National Law Review includes articles impacting the biotechnology, food, and drug industries. In the biotechnology realm, we examine many issues with a cross-over in intellectual property, such as licensing and patenting, intellectual property due diligence, litigation and tax. We also feature content on nanotechnology, biosimilars, greenhouse gas (GHG) regulation, biofuels and, biologics. Analysis includes actions by government entities such as the Food and Drug Administration (FDA), Food Safety and Inspection Service (FSIS), and United States Department of Agriculture (USDA). Common issues address by these agencies and in the industry include various food and beverage regulation, drug pricing and rebates, medical devices, country-of-origin labeling, nutrition labeling, and use of medical and recreational marijuana.

Date	Title	Organization
26 Jul	Massachusetts’s Highest Court Rules that Employee Fired for Medical Marijuana Use Can Hold Employer Liable for Discrimination	K&L Gates
26 Jul	Menu of the Day: Menu Labeling Requirements	Morgan, Lewis & Bockius LLP
26 Jul	Senate Armed Services Committee Directs DoD to Reduce Drug Prices	Covington & Burling LLP
26 Jul	GE Salmon Labeling Mandate Included in Senate Appropriations Bill	Keller and Heckman LLP
25 Jul	NIOSH Publishes Draft Chapter on Analysis of Carbon Nanotubes and Nanofibers on Filters by Transmission Electron Microscopy- Update	Bergeson & Campbell, P.C.
25 Jul	Witnesses at Congressional Hearing on 340B Urge Congress To Give HRSA Broader Regulatory Authority	Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
25 Jul	FDA Authorizes Qualified Health Claim for Macadamia Nuts	Keller and Heckman LLP
25 Jul	Federal Circuit Finds Velcade Patent Not Obvious Under Lead Compound Analysis	Foley & Lardner LLP
24 Jul	EPA Announces Public Hearing On RFS Program	Bergeson & Campbell, P.C.
24 Jul	FDA Publishes Final List of Class II Devices to be Exempted from 510(K) Process	Barnes & Thornburg LLP